Lower-middle income (World Bank) vs United States of America: Treatment success rate: XDR-TB cases
Lower-middle income (World Bank)
73
in 2022
United States of America
100
in 2021
Lower-middle income (World Bank) rank
2nd
United States of America rank
1st
Treatment success rate: XDR-TB cases over time
- Lower-middle income (World Bank)
- United States of America
How they compare
United States of America currently reports 100 against 73 in Lower-middle income (World Bank), a difference of 27.
That makes United States of America's figure about 1.4 times Lower-middle income (World Bank)'s.
The two have swapped places 5 times across 10 shared years of data; in 2010 it was Lower-middle income (World Bank) ahead.
Lower-middle income (World Bank) ranks 2nd and United States of America ranks 1st of 11 groups.
Across the 2 decades both report, Lower-middle income (World Bank) averaged higher in 1 and United States of America in 1.
Head to head by decade
| Decade | Lower-middle income (World Bank) | United States of America | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 34.5 | 68.5 | 34 | United States of America |
| 2020s | 67.5 | 50 | 17.5 | Lower-middle income (World Bank) |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate: xdr-tb cases, Lower-middle income (World Bank) or United States of America?
- United States of America, at 100 against 73 in Lower-middle income (World Bank) as of 2021.
- What is the difference in treatment success rate: xdr-tb cases between Lower-middle income (World Bank) and United States of America?
- 27, with United States of America ahead.
- How many years of comparable data are there for Lower-middle income (World Bank) and United States of America?
- 10 years are reported by both, from 2010 to 2021.
- How do Lower-middle income (World Bank) and United States of America rank globally for treatment success rate: xdr-tb cases?
- Lower-middle income (World Bank) ranks 2nd and United States of America ranks 1st of 11 groups.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate: XDR-TB cases. Statizoid refreshes it automatically from the source and publishes the full history for both places.